ZA98214B - Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. - Google Patents
Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.Info
- Publication number
- ZA98214B ZA98214B ZA9800214A ZA98214A ZA98214B ZA 98214 B ZA98214 B ZA 98214B ZA 9800214 A ZA9800214 A ZA 9800214A ZA 98214 A ZA98214 A ZA 98214A ZA 98214 B ZA98214 B ZA 98214B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- ingestion
- inhalation
- copolymer
- multiple sclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- General Preparation And Processing Of Foods (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11998997A IL119989A0 (en) | 1997-01-10 | 1997-01-10 | Pharmaceutical compositions for oral treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA98214B true ZA98214B (en) | 1999-08-11 |
Family
ID=11069682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9800214A ZA98214B (en) | 1997-01-10 | 1998-01-12 | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0975351B1 (de) |
| JP (1) | JP4216342B2 (de) |
| KR (1) | KR20000070058A (de) |
| CN (1) | CN100528222C (de) |
| AT (1) | ATE356608T1 (de) |
| AU (1) | AU737287B2 (de) |
| BR (1) | BRPI9807076B8 (de) |
| CA (1) | CA2277365C (de) |
| CZ (1) | CZ297983B6 (de) |
| DE (1) | DE69837324T2 (de) |
| EA (1) | EA003128B1 (de) |
| HK (1) | HK1025737A1 (de) |
| HU (1) | HU226612B1 (de) |
| IL (2) | IL119989A0 (de) |
| NZ (1) | NZ336690A (de) |
| PL (1) | PL193300B1 (de) |
| SK (1) | SK284029B6 (de) |
| WO (1) | WO1998030227A1 (de) |
| ZA (1) | ZA98214B (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7279172B2 (en) | 1998-07-23 | 2007-10-09 | Yeda Research And Development Co., Ltd. | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL140592A0 (en) * | 1998-07-23 | 2002-02-10 | Harvard College | Synthetic peptides and methods of use for autoimmune disease therapies |
| ES2527760T3 (es) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
| US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| DE60041365D1 (de) * | 1999-06-04 | 2009-02-26 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Verwendung von Riluzol zur Behandlung Multipler Sklerose |
| DE60017733T2 (de) * | 1999-06-04 | 2006-01-12 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Verwendung von riluzol zur behandlung multipler sklerose |
| AU2001238469C1 (en) * | 2000-02-18 | 2006-08-24 | Yeda Research And Development Co., Ltd. | Oral, nasal and pulmonary dosage formulations of copolymer 1 |
| ZA200206457B (en) | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
| US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| AU7528001A (en) * | 2000-06-05 | 2001-12-17 | Teva Pharma | The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| SI1459065T1 (sl) | 2001-12-04 | 2010-11-30 | Teva Pharma | Postopki za merjenje potentnosti glatiramer acetata |
| AR038605A1 (es) | 2002-02-25 | 2005-01-19 | Elan Pharm Inc | Uso de agentes para la manufactura de un medicamento para el tratamiento de inflamacion y composiciones para dicho tratamiento |
| EP3527228A1 (de) * | 2003-01-24 | 2019-08-21 | Biogen MA Inc. | Zusammensetzung zur behandlung von demyelinisierungskrankheiten und lähmungen durch verabreichung von remyelinisierungsmitteln |
| EP1797109B1 (de) | 2004-09-09 | 2016-02-24 | Yeda Research And Development Co., Ltd. | Mischungen von polypeptiden, zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung, und deren anwendungen |
| EP2405749B1 (de) | 2009-08-20 | 2013-05-08 | Yeda Research and Development Co., Ltd. | Niedrigfrequente glatiramerazetattherapie |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| US8759302B2 (en) | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| NZ609938A (en) | 2010-10-11 | 2015-11-27 | Teva Pharma | Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| TW201326399A (zh) | 2011-10-10 | 2013-07-01 | Teva Pharma | 用於預測對格拉替雷（ｇｌａｔｉｒａｍｅｒ）醋酸鹽之臨床反應之單核苷酸多型性之判定 |
| US9617596B2 (en) | 2012-10-10 | 2017-04-11 | Teva Pharmaceutical Industries, Ltd. | Biomarkers predictive for clinical response for glatiramer acetate |
| UY35790A (es) | 2013-10-21 | 2015-05-29 | Teva Pharma | Marcadores genéticos que predicen la respuesta al acetato de glatiramer |
| CN105884866B (zh) * | 2015-01-26 | 2021-04-20 | 漳州未名博欣生物医药有限公司 | 格拉替雷的化学合成方法 |
| US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
| WO2016172855A1 (zh) * | 2015-04-28 | 2016-11-03 | 深圳翰宇药业股份有限公司 | 多肽混合物高效液相色谱分析方法 |
| EP3600553A4 (de) | 2017-03-26 | 2020-09-02 | Mapi Pharma Ltd. | Glatiramerdepotsysteme zur behandlung progressiver formen von multipler sklerose |
| EP3645029B1 (de) | 2017-06-26 | 2023-01-18 | Institut Pasteur | Behandlungen zur eliminierung von hiv-reservoirs und verringerung der viruslast |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800808A (en) * | 1994-05-24 | 1998-09-01 | Veda Research And Development Co., Ltd. | Copolymer-1 improvements in compositions of copolymers |
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
-
1997
- 1997-01-10 IL IL11998997A patent/IL119989A0/xx unknown
-
1998
- 1998-01-12 AU AU58195/98A patent/AU737287B2/en not_active Expired
- 1998-01-12 PL PL334566A patent/PL193300B1/pl unknown
- 1998-01-12 ZA ZA9800214A patent/ZA98214B/xx unknown
- 1998-01-12 EP EP98901745A patent/EP0975351B1/de not_active Expired - Lifetime
- 1998-01-12 SK SK931-99A patent/SK284029B6/sk not_active IP Right Cessation
- 1998-01-12 CN CNB988031221A patent/CN100528222C/zh not_active Expired - Lifetime
- 1998-01-12 DE DE69837324T patent/DE69837324T2/de not_active Expired - Lifetime
- 1998-01-12 BR BRPI9807076A patent/BRPI9807076B8/pt not_active IP Right Cessation
- 1998-01-12 KR KR1019997006278A patent/KR20000070058A/ko active Search and Examination
- 1998-01-12 EA EA199900621A patent/EA003128B1/ru not_active IP Right Cessation
- 1998-01-12 WO PCT/US1998/000375 patent/WO1998030227A1/en active IP Right Grant
- 1998-01-12 CA CA2277365A patent/CA2277365C/en not_active Expired - Lifetime
- 1998-01-12 HU HU0001917A patent/HU226612B1/hu unknown
- 1998-01-12 AT AT98901745T patent/ATE356608T1/de not_active IP Right Cessation
- 1998-01-12 JP JP53110898A patent/JP4216342B2/ja not_active Expired - Lifetime
- 1998-01-12 NZ NZ336690A patent/NZ336690A/en not_active IP Right Cessation
- 1998-01-12 CZ CZ0243799A patent/CZ297983B6/cs not_active IP Right Cessation
-
1999
- 1999-07-06 IL IL130820A patent/IL130820A/en not_active IP Right Cessation
-
2000
- 2000-08-01 HK HK00104810A patent/HK1025737A1/xx not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7279172B2 (en) | 1998-07-23 | 2007-10-09 | Yeda Research And Development Co., Ltd. | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
Also Published As
| Publication number | Publication date |
|---|---|
| BR9807076B1 (pt) | 2013-10-29 |
| CZ243799A3 (cs) | 2000-06-14 |
| HUP0001917A3 (en) | 2001-12-28 |
| CA2277365C (en) | 2011-04-12 |
| EA199900621A1 (ru) | 2000-02-28 |
| DE69837324T2 (de) | 2007-11-29 |
| CN100528222C (zh) | 2009-08-19 |
| IL130820A (en) | 2007-03-08 |
| PL193300B1 (pl) | 2007-01-31 |
| NZ336690A (en) | 2001-05-25 |
| AU5819598A (en) | 1998-08-03 |
| DE69837324D1 (de) | 2007-04-26 |
| BR9807076A (pt) | 2000-05-02 |
| CN1249690A (zh) | 2000-04-05 |
| JP2001511121A (ja) | 2001-08-07 |
| PL334566A1 (en) | 2000-03-13 |
| JP4216342B2 (ja) | 2009-01-28 |
| HK1025737A1 (en) | 2000-11-24 |
| AU737287B2 (en) | 2001-08-16 |
| HUP0001917A2 (hu) | 2000-10-28 |
| IL119989A0 (en) | 1997-04-15 |
| WO1998030227A1 (en) | 1998-07-16 |
| SK284029B6 (sk) | 2004-08-03 |
| CZ297983B6 (cs) | 2007-05-16 |
| EP0975351A4 (de) | 2002-05-15 |
| SK93199A3 (en) | 2000-11-07 |
| ATE356608T1 (de) | 2007-04-15 |
| CA2277365A1 (en) | 1998-07-16 |
| KR20000070058A (ko) | 2000-11-25 |
| EP0975351A1 (de) | 2000-02-02 |
| HU226612B1 (en) | 2009-04-28 |
| EA003128B1 (ru) | 2003-02-27 |
| EP0975351B1 (de) | 2007-03-14 |
| BRPI9807076B8 (pt) | 2021-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1025737A1 (en) | Treatment of multiple sclerosis through ingestion of copolymer-1 | |
| IL113812A0 (en) | Copolymer-1, pharmaceutical compositions containing it and its use | |
| GB0129260D0 (en) | Pharmaceutical compositions and their uses | |
| BG103793A (en) | COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS | |
| UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
| EP0705100A4 (de) | Therapeutische substituierte guanidine | |
| IL108007A (en) | USE OF AN INTERFERON-GAMMA (IFN-gamma) INHIBITOR IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | |
| HK1028568A1 (en) | Alpha-ketoamide multicatalytic protease inhibitors | |
| IL141157A0 (en) | Salt form of pantoprazole and pharmaceutical compositions containing the same | |
| WO1996021468A3 (en) | Chemically modified interferon | |
| MXPA02010458A (es) | Peptido modulador del receptor de trombopoyetina. | |
| AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
| MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
| BG103632A (en) | Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment | |
| DK0977871T3 (da) | Neurotrypsin | |
| MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
| IL111804A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of constipation | |
| EP0714404A4 (de) | Antientzündliche peptide | |
| GB9015774D0 (en) | Novel treatment | |
| GR1002385B (el) | Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν. | |
| DE69929802D1 (en) | Lta4 hydrolase-hemmer | |
| TWI226833B (en) | Pharmaceutical composition for inhibiting bone resorption | |
| MY118194A (en) | Pharmaceutical compositions for use in inhibiting bone resorption |